Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Several Thoughts ... Apologies for the long post...

"Does the LG/Quanta decision greatly impact the total revenue TPL/PTSC can generate through litigation? If so, what is the potential revenue remaining given the impact? (Personally, I don't see this as an issue because TPL and PTSC have already addressed the issue, unlike some posters who will undoutedly surface again to use older quotes, not the updated quotes, to serve their purpose.)"

I agree with everything you said. I think the biggest hinderance in the J3 case in Texas was the fact that we sued AMD and intel (manufacturers) first and the LG/Quanta decision had nothing to do with the small amount we recieved.If you read the contract between AMD and PTSC we didn't allow ourselves any right to sue system manufactureers of their chips. That plus the fact that we represented all the other chips infringed as being part of a chip family instead of being specific.It cost too much money to bring these law suits if you are not going to, or have the ability to, bring your "A Game".If we continue with this type of strategy we will only get a discounted onetime fee in every industry for all past, present, and future infringement. That is totally ridiculous.

What we deserve was what was determined by the Markman hearing. What we got was because we were out smarted, out manned, and out lawyered.

Share
New Message
Please login to post a reply